Open AccessRecombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers
Author(s) -
Freddy J. Troost,
Wim H. M. Saris,
Robert Jan Brummer
Publication year - 2003
Publication title -
european journal of clinical nutrition
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 157
eISSN - 1476-5640
pISSN - 0954-3007
DOI - 10.1038/sj.ejcn.1601727
Subject(s) - lactoferrin , intestinal permeability , ingestion , lactulose , crossover study , medicine , placebo , enteropathy , small intestine , gastroenterology , pharmacology , endocrinology , chemistry , biochemistry , pathology , alternative medicine , disease
To determine whether recombinant human lactoferrin ingestion inhibits nonsteroidal antiinflammatory drugs (NSAID)-induced gastroenteropathy in vivo in healthy volunteers as a model for disorders associated with a rise in permeability of the stomach and the small intestine.